Active Pharmaceutical Ingredient Market to Reach USD 272.44 Billion Forecast by 2028

(MENAFN- The Express Wire)

Posted on Apr 18 2022 11:37 AM

'Active Pharmaceutical Ingredient market top key players are Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Mylan N.V., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Abbott, Biocon, Cipla Inc., Amgen Inc. and other key market players.'

The global active pharmaceutical ingredient (API) market is expected to gain impetus from the increasing prevalence of infectious diseases and cancer. It would further surge the demand for API to develop unique drugs. The National Cancer Institute estimated that in 2018, approximately 1,735,530 new cases of cancer were diagnosed. This is likely to increase up to 23.6 million by 2030. Fortune Business Insights™ published this information in a recently published report, titled,“ Active Pharmaceutical Ingredient (API) Market Size, Share & Industry Analysis, By Type (Generic API, and Branded API), By Synthesis (Biological API, and Synthetic API), and Regional Forecast, 2019-2026 .” The report further states that the API market size was USD 164.20 billion in 2018 and is projected to reach USD 261.28 billion by 2026, exhibiting a CAGR of 6.1% during the forecast period.

“Get Sample PDF of report, please connect with our sales team below.“

Email: sales [@] fortunebusinessinsights [.] com

Phone: US +1424 253 0390 / UK +44 2071 939123

Fortune Business Insights™ presents a list of all the companies operating in the industry. They are as follows:

• Aurobindo Pharma
• Teva Pharmaceutical Industries Ltd.
• Reddy's Laboratories Ltd.
• Mylan N.V.
• AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Abbott
• Biocon
• Cipla Inc.
• Amgen Inc.
• Other key market players

Rising Usage of Imported API for Developing Unique Products will Aid Growth

The Indian Brand Equity Foundation (IBEF) announced that the Indian pharmaceutical industry is anticipated to exhibit a CAGR 22.4% during 2015-2020. After India, the industry in China is considered to be the second largest. As the cases of chronic diseases are increasing rapidly day by day, there is a high demand for demand and biologics across the globe. Besides, in emerging countries, the utilization of imported API is increasing to develop highly innovative biopharmaceutical products. Several pharmaceutical companies globally are focusing mainly on research and development activities development activities to unveil state-of-the-art drugs. However, the frequent and unexpected changes in drug pricing policy, especially in the developing countries of the world may hamper the API market growth in the near future

Global Active Pharmaceutical Ingredient Market Highlights:

The burden of chronic diseases worldwide is rising rapidly owing to the increase in geriatric population, growing adoption of sedentary lifestyle, coupled with urbanization. This is creating an ever increasing demand for therapeutic drugs in the API market. According to the Indian Brand Equity Foundation (IBEF), the Indian pharmaceutical industry is projected to register a significant CAGR of 22.4% during 2015-2020. China's pharmaceutical industry is the only second fastest growing industry after India. The increasing complexity of chronic diseases and alarming rise in new cases of these diseases, have led to the rising demand for innovative drugs including biological drugs. Increasing demand for biologics and biosimilars is likely to drive the market growth during the forecast period. There has been an increase in the usage of imported raw pharmaceutical ingredients from emerging economies for the development of highly advanced biopharmaceutical products. Moreover, growing emphasis on research and development activities by many pharmaceutical firms for the introduction of innovative drugs in the market is likely to drive the API market growth during the forecast period.

Ask for Customization:

Email: sales [@] fortunebusinessinsights [.] com

Phone: US +1424 253 0390 / UK +44 2071 939123

Presence of Numerous Pharmaceutical Companies to Favor Growth in Asia Pacific

Geographically, North America procured USD 79.80 billion revenue in 2018. This growth is attributable to the increasing prevalence of chronic diseases in this region. Coupled with this, the rising government initiatives to develop innovative drugs would also contribute to the market growth here. Asia Pacific, on the other hand, is likely to outpace Europe and North America by exhibiting a high CAGR. It would mainly occur because of the increasing number of pharmaceutical companies and contract manufacturing organizations in India and China.

Highlights of the Report:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
• Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market

Active Pharmaceutical Ingredient Market Industry Competitive Analysis:

The Active Pharmaceutical Ingredient Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter's five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Inquire Before Buying This Research Report:

Email: sales [@] fortunebusinessinsights [.] com

Phone: US +1424 253 0390 / UK +44 2071 939123

Some major points from Table of Content:

• Introduction
• Research Scope
• Market Segmentation
• Research Methodology
• Definitions and Assumptions
• Executive Summary
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Key Insights
• Prevalence of Chronic Diseases -2018
• New Product Launches by Key Players
• Recent Industry Developments- Partnerships, Mergers, And Acquisitions
• Therapeutic Applications of the Different Types of Active Pharmaceutical Ingredient
• Global Market Analysis, Insights and Forecast, 2015-2026
• Key Findings / Summary
• Market Analysis, Insights and Forecast – By Type
• Generic API
• Branded API
• Market Analysis, Insights and Forecast – By Synthesis
• Biological API
• Synthetic API
• Market Analysis, Insights and Forecast – By Region
• North America
• Europe
• Asia Pacific
• Rest of World
• North America Industry Analysis, Insights and Forecast, 2015-2026
• Key Findings / Summary
• Market Analysis, Insights and Forecast – By Type
• Generic API

TOC Continued….

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

MENAFN18042022004576010663ID1104040721